Testing Meloxicam for Pain Relief in Mice with Viral Seizures
Author Information
Author(s): Weiß Edna, Pauletti Alberto, Egilmez Asya, Bröer Sonja
Primary Institution: Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin
Hypothesis
Can perioperative analgesia with meloxicam improve welfare without affecting experimental outcomes in a viral encephalitis model?
Conclusion
Meloxicam treatment did not improve well-being or affect key experimental outcomes in TMEV-infected mice.
Supporting Evidence
- Meloxicam did not affect seizure frequency or severity in TMEV-infected mice.
- Well-being scores did not differ significantly between treated and untreated groups.
- Weight loss was observed in TMEV mice, but not attributed to meloxicam treatment.
Takeaway
The study tested if giving mice a painkiller during a virus infection would help them feel better without changing the results of the experiment, but it didn't help.
Methodology
Mice were infected with TMEV and given meloxicam before surgery to assess its effects on well-being and experimental outcomes.
Potential Biases
Potential bias in pain assessment due to subjective scoring systems.
Limitations
Subjectivity in scoring well-being and the focus on a single dose of meloxicam may limit the findings.
Participant Demographics
58 male C57BL/6J mice aged five to six weeks.
Statistical Information
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website